0 Comentários
0 Compartilhamentos
4902 Visualizações
0 Anterior
Pesquisar
Conheça novas pessoas, crie conexões e faça novos amigos
- Faça Login para curtir, compartilhar e comentar!
- Antidiabetic Biosimilars Market Future Prospects and Forecast To 2030The report "Antidiabetic Biosimilars Market by Drug Class (Insulin, Biguanides, Sulfonyl Ureas, Thiazolidinediones, Di Peptidyl Peptidase (DPP)-IV Inhibitors, ?-glucosidase Inhibitos, GLP-1 Agonists, SGLT-2 Inhibitors, Others),by Disease Type (Type-I Diabetes, Type-II Diabetes), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region - Global Forecasts to...0 Comentários 0 Compartilhamentos 924 Visualizações 0 Anterior
- Antidiabetic Biosimilars Market Trends and Segments Forecast To 2029The global antidiabetic biosimilars market size was valued at x million in 2022 and is poised to grow at a significant CAGR of x% during the forecast period 2023-29. It also includes market size and projection estimations for each of the five major regions from 2023 to 2029. The research report includes historical data, trending features, and market growth estimates for the future....0 Comentários 0 Compartilhamentos 1524 Visualizações 0 Anterior
- Asia Pacific Biosimilars Market: Rapid Market Growth Fueled by Increased Healthcare Access and Investment Forecast 2032North America The North America Biosimilars Market is experiencing significant growth, primarily driven by the increasing demand for affordable biologic therapies and the rising adoption of biosimilars. The United States, with its large healthcare sector, represents the largest market in the region. Key factors contributing to the growth of the biosimilars market in North America...0 Comentários 0 Compartilhamentos 102 Visualizações 0 Anterior
- Asia Pacific Oncology Biosimilars Market Trends and Regional Forecast 2032North America The North America Oncology Biosimilars Market is expanding rapidly, largely driven by the increasing prevalence of cancer and the high cost of biologic treatments. The United States dominates this market with extensive biosimilar approvals by the FDA, a robust healthcare infrastructure, and initiatives to reduce healthcare costs. Canada is also experiencing growth due to...0 Comentários 0 Compartilhamentos 99 Visualizações 0 Anterior
- Autoimmune Solutions: The Rising Role of Biosimilars in Disease ManagementBiosimilars Market: A Breakdown by Therapeutic Area (2024) The biosimilars market is experiencing significant growth, driven by factors like patent expirations on biologics and increasing healthcare cost pressures. This trend is particularly evident in several key therapeutic areas. Let's explore some of the top questions regarding biosimilars across these areas: 1. Which therapeutic area is...0 Comentários 0 Compartilhamentos 599 Visualizações 0 Anterior
- Automation Set To Accelerate Growth Of The Global Biosimilars MarketThe global Biosimilars Market is estimated to be valued at US$ 29.4 Bn in 2023 and is expected to exhibit a CAGR of 17% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview:Biosimilars are biologics that are highly similar to an approved biological drug known as the reference biologic product. Biosimilars offer advantages...0 Comentários 0 Compartilhamentos 1582 Visualizações 0 Anterior
- Bevacizumab Biosimilars in 2024: Analyzing Market Potential and ForecastsBevacizumab - Biosimilars Insight, 2024 Bevacizumab, a monoclonal antibody developed by Genentech and marketed under the brand name Avastin, has been a significant player in the oncology landscape since its approval. It is primarily used for treating various cancers, including metastatic colorectal cancer, non-small cell lung cancer, and glioblastoma multiforme. The drug works by...0 Comentários 0 Compartilhamentos 528 Visualizações 0 Anterior
- Bevacizumab Biosimilars: Key Developments and Market Forecast for 2024Bevacizumab - Biosimilars Insight, 2024 Introduction Bevacizumab, a monoclonal antibody, has transformed the landscape of oncology since its approval. Known for its efficacy in treating various cancers, including colorectal, lung, and renal, it works by targeting vascular endothelial growth factor (VEGF). This article provides an overview of Bevacizumab and its biosimilars, focusing on...0 Comentários 0 Compartilhamentos 466 Visualizações 0 Anterior
- Biosimilars And Follow-On Biologics Market Size, Overview, Share and Forecast 2031The Biosimilars And Follow-On Biologics Market in 2023 is US$ 26.03 billion, and is expected to reach US$ 83.69 billion by 2031 at a CAGR of 15.70%. FutureWise Research published a report that analyzes Biosimilars And Follow-On Biologics Market trends to predict the market's growth. The report begins with a description of the business environment and explains the commercial summary of the chain...0 Comentários 0 Compartilhamentos 1074 Visualizações 0 Anterior
- AstraZeneca’s Precision Medicine in Biologics: The Role of AI and GenomicsInnovations and Tech Developments in the Microbiology Testing Industry: A Deep Dive into Leading Companies The microbiology testing industry is evolving rapidly, driven by technological advancements that enhance diagnostics, pathogen detection, and laboratory workflows. Several global players are at the forefront of these developments, offering state-of-the-art solutions to tackle the growing...0 Comentários 0 Compartilhamentos 142 Visualizações 0 Anterior
- Biosimilar Revolution: Enhancing Treatment Accessibility and Affordability for Chronic Diseases with Remicade AlternativesRemicade is a biologic medication that has been used effectively to treat several chronic inflammatory conditions such as rheumatoid arthritis, Crohn's disease, and ulcerative colitis. However, its high costs have put it out of reach for many patients. Fortunately, biosimilar versions of Remicade have now entered the market, providing more affordable treatment options. This article aims to...0 Comentários 0 Compartilhamentos 1368 Visualizações 0 Anterior
Páginas Impulsionadas